Article: Therapeutics for Substance-Using Women: The Need to Elucidate Sex-Specific Targets for Better-Tailored Treatments.
Handbook of experimental pharmacology
2023 Volume 282, Page(s) 127–161
Abstract: In the last decade, alcohol consumption in the US has risen by 84% in women compared with 35% in men. Furthermore, research has shown that sex- and gender-related differences may disadvantage women in terms of developing a range of psychological, ... ...
| Abstract | In the last decade, alcohol consumption in the US has risen by 84% in women compared with 35% in men. Furthermore, research has shown that sex- and gender-related differences may disadvantage women in terms of developing a range of psychological, cognitive, and medical problems considerably earlier in their drinking history than men, and despite consuming a similar quantity of substances. While this "telescoping" process has been acknowledged in the literature, a concomitant understanding of the underlying biobehavioral mechanisms, and an increase in the development of specific treatments tailored to women, has not occurred. In the current chapter we focus on understanding why the need for personalized, sex-specific medications is imperative, and highlight some of the potential sex-specific gonadal and stress-related adaptations underpinning the accelerated progress from controlled to compulsive drug and alcohol seeking in women. We additionally discuss the efficacy of these mechanisms as novel targets for medications development, using exogenous progesterone and guanfacine as examples. Finally, we assess some of the challenges faced and progress made in terms of developing innovative medications in women. We suggest that agents such as exogenous progesterone and adrenergic medications, such as guanfacine, may provide some efficacy in terms of attenuating stress-induced craving for several substances, as well as improving the ability to emotionally regulate in the face of stress, preferentially in women. However, to fully leverage the potential of these therapeutics in substance-using women, greater focus needs to the placed on reducing barriers to treatment and research by encouraging women into clinical trials. |
|---|---|
| MeSH term(s) | Male ; Humans ; Female ; Guanfacine/pharmacology ; Guanfacine/therapeutic use ; Progesterone/therapeutic use ; Alcohol Drinking ; Ethanol |
| Chemical Substances | Guanfacine (30OMY4G3MK) ; Progesterone (4G7DS2Q64Y) ; Ethanol (3K9958V90M) |
| Language | English |
| Publishing date | 2023-08-17 |
| Publishing country | Germany |
| Document type | Journal Article |
| ISSN | 0171-2004 |
| ISSN | 0171-2004 |
| DOI | 10.1007/164_2023_687 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Sign. bis Bd. 125 (1997): 1982 A 2146: Show issues | ||||
| danach: Sign. bei den Einzelbänden: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.